Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management.

Introduction: Pediatric attention-deficit disorder (ADHD) impacts a significant percentage of the population world-wide. Pharmacologic treatments have been shown to be safe and effective for managing symptoms. Various medication formulations exist, and new medication agents are continually approved each year.

A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery.

Purpose: To compare the effects of 2 corticosteroids on corneal thickness and visual acuity after cataract surgery.

Design: Multicenter, randomized, contralateral-eye, double-masked trial.

Methods: Fifty-two patients (104 eyes) underwent bilateral phacoemulsification.